VNDA icon

Vanda Pharmaceuticals
VNDA

Overview Fund Activity

157 hedge funds and large institutions have $222M invested in Vanda Pharmaceuticals in 2023 Q4 according to their latest regulatory filings, with 26 funds opening new positions, 53 increasing their positions, 56 reducing their positions, and 47 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
157
Holders Change
-22
Holders Change %
-12.29%
% of All Funds
2.3%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
26
Increased
53
Reduced
56
Closed
47
Calls
$211K
Puts
$88K
Net Calls
+$123K
Net Calls Change
+$171K

Top Buyers

1
Morgan Stanley
1
Morgan Stanley
New York
$17.1M
2
BlackRock
2
BlackRock
New York
$35.2M
3
Acadian Asset Management
3
Acadian Asset Management
Massachusetts
$9.55M
4
Jacobs Levy Equity Management
4
Jacobs Levy Equity Management
New Jersey
$6.03M
5
Renaissance Technologies
5
Renaissance Technologies
New York
$15.5M

Top Sellers

1
Goldman Sachs
1
Goldman Sachs
New York
$1.95M
2
Millennium Management
2
Millennium Management
New York
$4.21M
3
SCM
3
Stonepine Capital Management
Oregon
$0
4
Susquehanna International Group
4
Susquehanna International Group
Pennsylvania
$1.02M
5
KAM
5
Krensavage Asset Management
New York
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
HNB
201
Huntington National Bank
Ohio
– -$3.75K -867 Closed
IA
202
IFP Advisors
Florida
– -$1.27K -295 Closed
AF
203
Allworth Financial
California
– -$424 -98 Closed
Fifth Third Bancorp
204
Fifth Third Bancorp
Ohio
– -$225 -52 Closed
Man Group
205
Man Group
United Kingdom
– -$1.18M – –
5 6 7 8
9